Neurotoxic effects of thioflavin S-positive amyloid deposits in transgenic mice and Alzheimer's disease
AUTOR(ES)
Urbanc, B.
FONTE
National Academy of Sciences
RESUMO
Despite extensive deposition of putatively neurotoxic amyloid-β (Aβ) protein in the brain, it has not been possible to demonstrate an association of Aβ deposits with neuronal loss in Alzheimer's disease (AD), and neuronal loss is minimal in transgenic mouse models of AD. Using triple immunostaining confocal microscopy and analyzing the images with the cross-correlation density map method from statistical physics, we directly compared Aβ deposition, Aβ morphology, and neuronal architecture. We found dramatic, focal neuronal toxicity associated primarily with thioflavin S-positive fibrillar Aβ deposits in both AD and PSAPP mice. These results, along with computer simulations, suggest that Aβ develops neurotoxic properties in vivo when it adopts a fibrillar β-pleated sheet conformation.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=137824Documentos Relacionados
- Therapeutic effects of PKC activators in Alzheimer's disease transgenic mice
- Immune hyporesponsiveness to amyloid β-peptide in amyloid precursor protein transgenic mice: Implications for the pathogenesis and treatment of Alzheimer's disease
- Enhanced neurogenesis in Alzheimer's disease transgenic (PDGF-APPSw,Ind) mice
- Inflammatory cytokine levels correlate with amyloid load in transgenic mouse models of Alzheimer's disease
- Relationship of amyloid to Alzheimer's disease.
